We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SCLP market cap is 129.89M. The company's latest EPS is GBP -0.0129 and P/E is -10.85.
| Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 5.27M |
| Operating Income | -6.73M | -6.78M | -8.83M | -13.3M | -11.56M |
| Net Income | -5.63M | -5.51M | -15.48M | -4.57M | -11.94M |
| Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 10.54M | 8.82M | 49.06M | 38.52M | 30.27M |
| Total Liabilities | 1.21M | 1.17M | 29.57M | 33.71M | 36.5M |
| Total Equity | 9.34M | 7.65M | 19.49M | 4.81M | -6.23M |
| Year End April 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -7.03M | -4.77M | -7.8M | -10.19M | -8.14M |
| Investing | 13k | -13k | -741k | -1.26M | 81k |
| Financing | 1.28M | 3.8M | 46.08M | -928k | -746k |
| Market Cap | 129.89M |
| Price to Earnings Ratio | -10.85 |
| Price to Sales Ratio | 24.56 |
| Price to Cash Ratio | 6.51 |
| Price to Book Ratio | -20.84 |
| Dividend Yield | - |
| Shares Outstanding | 927.82M |
| Average Volume (1 week) | 1.26M |
| Average Volume (1 Month) | 794.68k |
| 52 Week Change | 30.23% |
| 52 Week High | 18.125 |
| 52 Week Low | 7.65 |
| Spread (Intraday) | 1 (6.9%) |
| Company Name | Scancell Holdings Plc |
| Address |
bellhouse building oxford OX4 4GD |
| Website | https://\www.scancell.co.uk |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
